| # | Drug | Count |
|---|---|---|
| 0 | METFORMIN | 85 |
| 1 | METFORMIN ER 500 MG | 76 |
| 2 | METFORMIN ER 750 MG | 76 |
| 3 | SITAGLIPTIN | 72 |
| 4 | PANCRELIPASE | 71 |
| 5 | ASPIRIN | 65 |
| 6 | ASPIRIN 325 MG | 62 |
| 7 | ASPIRIN 81 MG | 62 |
| 8 | FUROSEMIDE | 60 |
| 9 | PREDNISONE | 58 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.1667 |
| 1 | FORMALDEHYDE | 1 | 0.0164 |
| 2 | CAFFEINE, MAGNESIUM SALICYLATE | 1 | 0.0039 |
| 3 | PHENAZOPYRIDINE HYDROCHLORIDE | 1 | 0.0030 |
| 4 | GLYCOPYRROLATE | 17 | 0.0030 |
| 5 | PAMABROM | 1 | 0.0027 |
| 6 | SAXAGLIPTIN | 4 | 0.0027 |
| 7 | ASIAN GINSENG | 1 | 0.0024 |
| 8 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 2 | 0.0020 |
| 9 | PANCRELIPASE | 71 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 120 |
| 1 | Corticosteroid [EPC] | 116 |
| 2 | GLP-1 Receptor Agonist [EPC] | 112 |
| 3 | Insulin Analog [EPC] | 73 |
| 4 | Benzodiazepine [EPC] | 68 |
| 5 | Proton Pump Inhibitor [EPC] | 67 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 66 |
| 7 | Loop Diuretic [EPC] | 65 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 57 |
| 9 | Vitamin C [EPC] | 52 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 1 | 0.0011 |
| 1 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |
| 2 | Progestin Antagonist [EPC] | 3 | 0.0006 |
| 3 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 4 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 5 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 6 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 7 | Ergot Derivative [EPC] | 2 | 0.0004 |
| 8 | Macrolide Antimicrobial [EPC] | 20 | 0.0004 |
| 9 | GLP-2 Analog [EPC] | 5 | 0.0004 |